QR kód

Ceftazidime/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing Klebsiella pneumoniae and Hinders Emergence of Resistant Subpopulation in vitro

Due to the increasing multidrug resistance and limited antibiotics, polymyxin B revived as the last resort for the treatment of carbapenemase-producing Klebsiella pneumoniae (CRKP). Unfortunately, the heteroresistance hampers polymyxin B monotherapy treatment via the amplification of resistant subpo...

Celý popis

Uloženo v:
Hlavní autoři: Xingyan Ma, Yuting He, Xuegao Yu, Yimei Cai, Jianming Zeng, Renxin Cai, Yang Lu, Liang Chen, Cha Chen, Bin Huang
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019-09-01
Edice:Frontiers in Microbiology
Témata:
ceftazidime/avibactam
polymyxin B
heteroresistance
KPC-2-producing Klebsiella pneumoniae
bacterial killing activity
On-line přístup:https://www.frontiersin.org/article/10.3389/fmicb.2019.02029/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky